NAPA, California, February 12 /PRNewswire/ --
- Dr. Mark Nestor to Present Rosacea Study Results on February 13, 2009 -
Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that target the science of healthy aging, announced today that positive study results from a clinical trial of Pyratine-XR(TM) in patients with rosacea will be presented February 13, 2009, at the 7th Annual South Beach Clinical Dermatology Symposium in Miami, Florida.
Dr. Mark Nestor, the Symposium chair, will be presenting Cytokinins: Cutaneous Aging and Rosacea at 4:45 PM.